Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Hite Christopher, Director. Insider active across 2 companies, notably Acceleron Pharma INC. Cumulatively, 12 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €5.2m. History available since 13 May 2024. The latest transaction was disclosed on 18 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
Hite Christopher is Administrateur and is reported in 10 filings in total. The recent filings sampled run from 2021-11-22 to 2026-08-07, concern Royalty Pharma plc, and the modal transaction nature is Attribution. In these sampled recent filings, the reported buy and sell amounts are 0 and 0.